Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Clarity Pharmaceuticals Ltd. ( (AU:CU6) ) has issued an announcement.
Clarity Pharmaceuticals Limited has announced that Alan John Taylor has ceased to be a substantial holder in the company as of August 1, 2025. This change is due to a dilution of shares following a recent placement announced on July 28, 2025, which affected the voting securities held by Taylor and associated entities. The impact of this announcement indicates a shift in shareholder dynamics, potentially influencing the company’s governance and stakeholder interests.
The most recent analyst rating on (AU:CU6) stock is a Buy with a A$8.20 price target. To see the full list of analyst forecasts on Clarity Pharmaceuticals Ltd. stock, see the AU:CU6 Stock Forecast page.
More about Clarity Pharmaceuticals Ltd.
Average Trading Volume: 3,098,329
Technical Sentiment Signal: Buy
Current Market Cap: A$1.4B
For detailed information about CU6 stock, go to TipRanks’ Stock Analysis page.